Imaging mass spectrometry further validated these findings, demonstrating a significant decrease in the density of CD169+ macrophages in metastatic lymph nodes, which negatively correlated with the pathological staging (pN classification) of breast cancer. The gene discussed is SIGLEC1; the disease is breast carcinoma.